Azithromycin Suspension Solicitation

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-25-R-0001

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents2
The Defense Logistics Agency (DLA) Troop Support has issued a presolicitation notice for the procurement of Azithromycin Suspension, as indicated by Procurement Identifier SPE2D2-25-R-0001. This opportunity falls under the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, denoting Drugs and Biologicals. The notice is intended to inform potential contractors of the upcoming solicitation and any amendments, such as the attached extension of the closing date. The primary objective of this procurement is to secure a reliable supply of Azithromycin Suspension, a critical pharmaceutical product used in various medical treatments. The scope of the contract will likely encompass the manufacturing, packaging, and delivery of this medication in accordance with federal standards and DLA requirements. While specific quantities, packaging specifications, and delivery schedules are not detailed in the presolicitation, contractors should anticipate the need to comply with stringent quality assurance and regulatory guidelines typical of federal pharmaceutical contracts. DLA Troop Support, a federal office responsible for providing medical and pharmaceutical supplies to military and federal entities, is the contracting authority for this requirement. The procurement is managed out of their office, and interested parties may direct inquiries to the designated contacts: Kahaun Vicks ([email protected], 215-737-0652) and Jason C. Wray ([email protected], 215-737-0614). These contacts can provide further clarification regarding the solicitation process and requirements. The notice is currently marked as inactive, and the response window has closed as of February 12, 2024. However, the attached amendment indicates that the closing date was extended, suggesting that interested contractors should review the associated documents for updated timelines and submission instructions. The opportunity was posted on the federal procurement platform SAM.gov, and additional details, including attachments, can be accessed via the provided URL. No information is provided regarding set-aside requirements, special considerations, or the specific procurement method (e.g., full and open competition, small business set-aside). Contractors specializing in pharmaceutical manufacturing, particularly those with experience supplying federal agencies, should review the presolicitation and any subsequent solicitation documents for comprehensive requirements and eligibility criteria. In summary, this procurement represents an opportunity for qualified pharmaceutical manufacturers to supply Azithromycin Suspension to DLA Troop Support, supporting the agency’s mission to ensure the availability of essential medical supplies for federal and military use. Contractors are encouraged to monitor the SAM.gov listing for updates and to engage with the listed contacts for further information.